We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Chinese Firms End Up on FDA’s GMP Import Alert, Refuse to Inspect Lists
Chinese Firms End Up on FDA’s GMP Import Alert, Refuse to Inspect Lists
The list of Chinese pharmaceutical companies in the FDA’s crosshairs keeps on growing, with the agency hitting two drugmakers for GMP violations and another for refusing an inspection.